BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31675126)

  • 1. Breast cancer incidence and mortality before and after implementation of the German mammography screening program.
    Katalinic A; Eisemann N; Kraywinkel K; Noftz MR; Hübner J
    Int J Cancer; 2020 Aug; 147(3):709-718. PubMed ID: 31675126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Breast Cancer Incidence and Stage Distribution Before and During the Introduction of the Mammography Screening Program in Lithuania.
    Steponaviciene L; Briediene R; Vanseviciute R; Smailyte G
    Cancer Control; 2019; 26(1):1073274818821096. PubMed ID: 30808202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in advanced breast cancer incidence rates after implementation of a mammography screening program in a German population.
    Simbrich A; Wellmann I; Heidrich J; Heidinger O; Hense HW
    Cancer Epidemiol; 2016 Oct; 44():44-51. PubMed ID: 27470937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.
    Jacklyn G; McGeechan K; Irwig L; Houssami N; Morrell S; Bell K; Barratt A
    Breast Cancer Res Treat; 2017 Dec; 166(3):843-854. PubMed ID: 28822001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of breast cancer screening in a population with high spontaneous coverage with mammography.
    Capodaglio G; Zorzi M; Tognazzo S; Greco A; Michieletto F; Fedato C; Montaguti A; Turrin A; Ferro A; Cinquetti S; Russo F; Corti MC; Rugge M; Fedeli U
    Tumori; 2018 Aug; 104(4):258-265. PubMed ID: 30079815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
    Welch HG; Prorok PC; O'Malley AJ; Kramer BS
    N Engl J Med; 2016 Oct; 375(15):1438-1447. PubMed ID: 27732805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
    Coldman A; Phillips N
    CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
    Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
    Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
    Anderson WF; Jatoi I; Devesa SS
    Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in breast cancer by race and ethnicity: update 2006.
    Smigal C; Jemal A; Ward E; Cokkinides V; Smith R; Howe HL; Thun M
    CA Cancer J Clin; 2006; 56(3):168-83. PubMed ID: 16737949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976-2009.
    Parvinen I; Heinävaara S; Anttila A; Helenius H; Klemi P; Pylkkänen L
    Br J Cancer; 2015 Mar; 112(5):918-24. PubMed ID: 25688742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria.
    Oberaigner W; Geiger-Gritsch S; Edlinger M; Daniaux M; Knapp R; Hubalek M; Siebert U; Marth C; Buchberger W
    Breast; 2017 Jun; 33():178-182. PubMed ID: 28419909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
    Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage distribution of breast cancer diagnosed before and after implementation of population-based mammographic screening.
    Hofvind S; Skaane P
    Rofo; 2012 May; 184(5):437-42. PubMed ID: 22426937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of population-based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow-up.
    Sankatsing VDV; van Ravesteyn NT; Heijnsdijk EAM; Looman CWN; van Luijt PA; Fracheboud J; den Heeten GJ; Broeders MJM; de Koning HJ
    Int J Cancer; 2017 Aug; 141(4):671-677. PubMed ID: 28457023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in late-stage breast cancer incidence in the mammography era: Implications for overdiagnosis of invasive cancer.
    Helvie MA; Chang JT; Hendrick RE; Banerjee M
    Cancer; 2014 Sep; 120(17):2649-56. PubMed ID: 24840597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammography use and mode of detection among breast cancer patients in Estonia.
    Innos K; Valvere V; Padrik P; Eelma E; Kütner R; Lehtsaar J; Tekkel M
    Women Health; 2016; 56(2):129-40. PubMed ID: 26327255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer incidence and overdiagnosis in Catalonia (Spain).
    Martinez-Alonso M; Vilaprinyo E; Marcos-Gragera R; Rue M
    Breast Cancer Res; 2010; 12(4):R58. PubMed ID: 20682042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in surgical treatment for breast cancer in Germany after the implementation of the mammography screening program.
    Trocchi P; Kuss O; Kääb-Sanyal V; Heidinger O; Stang A
    Eur J Epidemiol; 2019 Dec; 34(12):1143-1150. PubMed ID: 31650416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.